Structure Therapeutics American Stock Price on December 2, 2024

GPCR Stock   34.70  0.02  0.06%   
If you're considering investing in Structure Stock, it is important to understand the factors that can impact its price. As of today, the current price of Structure Therapeutics stands at 34.70, as last reported on the 11th of December 2024, with the highest price reaching 36.15 and the lowest price hitting 34.10 during the day. Structure Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0409, which indicates the firm had a -0.0409% return per unit of risk over the last 3 months. Structure Therapeutics American exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Structure Therapeutics' Semi Deviation of 3.5, coefficient of variation of 6416.25, and Risk Adjusted Performance of 0.0196 to confirm the risk estimate we provide.
  
At this time, Structure Therapeutics' Issuance Of Capital Stock is relatively stable compared to the past year. . At this time, Structure Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 12/11/2024, Price To Book Ratio is likely to grow to 3.47, while Price Earnings To Growth Ratio is likely to drop (0.24). Structure Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0409

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsGPCR

Estimated Market Risk

 3.94
  actual daily
35
65% of assets are more volatile

Expected Return

 -0.16
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average Structure Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Structure Therapeutics by adding Structure Therapeutics to a well-diversified portfolio.
Price Book
2.1294
Book Value
9.761
Enterprise Value
998.7 M
Enterprise Value Ebitda
(13.46)
Shares Float
153.5 M

Related Headline

Terns Pharmaceuticals Headline on 2nd of December 2024

FOSTER CITY, Calif., Dec. 02, 2024 -- Terns Pharmaceuticals, Inc. , a clinical-stage biopharmaceu

Structure Therapeutics Valuation on December 2, 2024

It is possible to determine the worth of Structure Therapeutics on a given historical date. On December 2, 2024 Structure was worth 32.97 at the beginning of the trading date compared to the closed value of 33.94. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Structure Therapeutics stock. Still, in general, we apply an absolute valuation method to find Structure Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Structure Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Structure Therapeutics' related companies.
 Open High Low Close Volume
  33.78    34.64    32.83    33.15    240,485  
12/02/2024
  32.97    34.96    32.97    33.94    586,724  
  33.89    34.19    32.97    33.25    844,678  
Backtest Structure Therapeutics  |  Structure Therapeutics History  |  Structure Therapeutics Valuation   PreviousNext  
Open Value
32.97
33.94
Closing Value
44.78
Upside

Structure Therapeutics Trading Date Momentum on December 2, 2024

On December 03 2024 Structure Therapeutics American was traded for  33.25  at the closing time. The top price for the day was 34.19  and the lowest listed price was  32.97 . The trading volume for the day was 844.7 K. The trading history from December 3, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.03% . The trading price change against the current closing price is 3.12% .

Structure Therapeutics Fundamentals Correlations and Trends

By evaluating Structure Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Structure Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Structure financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Structure Therapeutics Stock history

Structure Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Structure is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Structure Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Structure Therapeutics stock prices may prove useful in developing a viable investing in Structure Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding36.7 M40.3 M
Net Loss-39.4 M-41.4 M

Structure Therapeutics Quarterly Net Working Capital

890.22 Million

Structure Therapeutics Stock Technical Analysis

Structure Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Structure Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Structure Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Structure Therapeutics Period Price Range

Low
December 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Structure Therapeutics American cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Structure Therapeutics December 11, 2024 Market Strength

Market strength indicators help investors to evaluate how Structure Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Structure Therapeutics shares will generate the highest return on investment. By undertsting and applying Structure Therapeutics stock market strength indicators, traders can identify Structure Therapeutics American entry and exit signals to maximize returns

Structure Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Structure Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Structure Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Structure to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Structure Stock Analysis

When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.